Biochemical Reagent
-
BA8580 PF-06273340Summary: A potent, orally active, selective peripherally restricted pan-inhibitor. - BA8581 TrkA-IN-3Summary: TrkA-IN-3 is a potent and subselective metastable inhibitor.
- BA8582 UtatrectinibSummary: Utatrectinib (AZD-7451) is a potent, selective and orally active inhibitor.
- BA8583 ENT-C225Summary: ENT-C225 is a potent neurotrophin receptor activator.
- BA8584 TrkA-IN-4Summary: TrkA-IN-4 is a potent and orally active alterative inhibitor of the precursor (=22.4 nM).
- BA8585 UtreloxastatSummary: A compound for use in the study of diseases including alpha-synucleinopathies, tauopathies, ALS, traumatic brain injury, and ischemia-reperfusion related injury.
- BA8586 SynuClean-DSummary: SynuClean-D (SC-D) is an inhibitor of α-synuclein aggregation.
- BA8587 ELN484228Summary: ELN484228 is a blocker of alpha-synuclein.
- BA8588 MinzasolminSummary: Inhibitors of alpha-synuclein oligomerization.
- BA8589 BPN-15606Summary: BPN-15606 is a potent oral activity modulator (GSM) that attenuates SHSY5Y neuroblastoma cell production.